BioLineRx to Report Third Quarter 2025 Results on November 24, 2025

Management to Hold Conference Call at 8:30 a.m. EST Learn more about who we are, what we do, and how we do it atwww.biolinerx.com, or onLinkedIn. CONTACTS: United States Irina Koffler LifeSci Advisors, LLC [email protected] Israel Moran Meir LifeSci Advisors, LLC [email protected] Logo: https://mma.prnewswire.com/media/2154863/BioLineRx_Ltd_Logo.jpg , /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a development stage biopharmaceutical company pursuing life-changing therapies in oncology and ...